Dr. Catherine M. Reppa, MD

Dr. Reppa practices at Ttuhsc - Opthalmology in Lubbock, Texas.

Dr. Reppa's NPI, 1548527047, was assigned on April 20, 2012. Dr. Reppa graduated from Joe R. & Teresa Lozano Long School of Medicine in 2012. Dr. Reppa holds Texas license R4308.

Dr. Reppa's primary practice is Ttuhsc - Opthalmology, at 3601 4th St, Lubbock, TX 79415 in Lubbock County. The practice phone is (806) 743-2020.

Dr. Reppa's primary practice is Ttuhsc - Opthalmology in Lubbock, Texas. Dr. Reppa is also affiliated with University Medical Center. The medical group on file is Texas Tech Physicians. Dmand AI also links Dr. Reppa to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Reppa practices, 3 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Reppa's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Reppa is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Reppa's licenses on file in 4 states: Texas, Missouri, North Carolina and Pennsylvania.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, cold sores or genital herpes, conjunctivitis, dry eye, eye infection or inflammation and eyelid inflammation among the conditions Dr. Reppa treats.

CMS data shows 344 Medicare services from Dr. Reppa across 7 procedure codes in 2024, for 157 Medicare patients. Medicare paid $41,019 for them.

CMS counts 157 Medicare patients who saw Dr. Reppa in 2024. The largest group is 65 to 74, with 65 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 1.27, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Reppa's median patient age at 72, with 64% women.

In 2024, Dr. Reppa wrote 459 Medicare Part D claims for 142 patients. 47% of them were for generic drugs. CMS names the drug for 413 of them, across 10 drugs with 11 or more claims each, at $13,674 in total drug cost. In 2023, CMS named 598 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Reppa for performance year 2024, reported through an alternative payment model (APM). Dr. Reppa accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 88 procedures of cataract surgery by Dr. Reppa, more than 72% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. Reppa in 2019. The most frequent topics are Cornea. Dr. Reppa's most frequent co-authors are Joel Palko, MD, Maxwell William Dixon, MD and Asim V. Farooq.

CMS Open Payments shows 23 general payments to Dr. Reppa from 7 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Abbott Laboratories paid the most, $379.

Dr. Reppa graduated from Joe R. & Teresa Lozano Long School of Medicine in 2012.

Dr. Reppa is in network with 18 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.